Lymphatic ERG regulates lung inflammation and impacts lymphatic interactions with immune cells
This study demonstrates that the transcription factor ERG is essential for maintaining lymphatic endothelial identity and regulating immune cell interactions in the lung, as its downregulation disrupts lymphatic function and promotes inflammation and fibrosis in interstitial lung disease.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Inside the human chest, the lungs are not just bags of air; they are a bustling ecosystem where oxygen is exchanged and waste is cleared. To keep this environment healthy, the body relies on a hidden network of tiny vessels called lymphatics. Think of these vessels as the city's sanitation system, constantly draining excess fluid and carrying away debris to prevent swelling and infection. When this system fails, fluid builds up, and the delicate tissues can become inflamed and scarred. This is a central problem in a group of diseases known as interstitial lung disease, where the lung tissue thickens and stiffens, making it hard to breathe. While scientists have long studied the blood vessels that feed the lungs, the lymphatic network has remained somewhat mysterious, particularly regarding the specific molecular switches that tell these vessels how to behave and how to talk to the immune cells patrolling the tissue.
Researchers at Boston University have now turned their attention to one such switch, a protein called ERG. In the world of blood vessels, ERG is known as a master regulator, a molecule that helps keep the vessel walls strong and calm, preventing them from becoming leaky or inflamed. The team wanted to know if this same protein played a similar role in the lymphatic vessels of the lungs. They focused their investigation on patients with systemic sclerosis, an autoimmune disease that often leads to severe lung scarring. By examining lung tissue from these patients, they discovered a striking pattern: the lymphatic vessels were present, but they had lost most of their ERG protein. In healthy lungs, ERG was abundant in these vessels, but in the diseased lungs, it had vanished, even though the nearby blood vessels still held onto it. This suggested that the loss of ERG was specific to the lymphatic system and might be a key factor in the disease process.
To understand what happens when lymphatic vessels lose this protein, the scientists created a special group of mice. They engineered these animals so that they could turn off the gene for ERG specifically in their lung lymphatic cells, leaving the rest of the body untouched. When they switched off the gene, the mice did not immediately develop the thick, scarred lungs seen in severe fibrosis. Instead, something more subtle occurred first. The lungs of these mice began to fill with immune cells. The researchers found a significant increase in various types of white blood cells, including monocytes and dendritic cells, which are the body's first responders to injury. The tissue became inflamed, and the genetic instructions inside the lung cells shifted toward a state of high alert, turning on pathways associated with infection and repair.
The study revealed that the absence of ERG caused the lymphatic cells to lose their identity. Normally, these cells carry a specific set of instructions that tell them to function as lymphatic vessels, maintaining their unique shape and job. Without ERG, the cells stopped producing key proteins like PROX1 and FLT4, which are essential for keeping them on the right path. It was as if the sanitation workers had forgotten their uniforms and their training, becoming confused and ineffective. Furthermore, the loss of ERG triggered a surge in a specific type of immune signaling known as the interferon pathway. This pathway is often associated with the body's response to viruses, but in this case, it appeared to be driving chronic inflammation in the lung tissue. The researchers confirmed this finding by taking human lung lymphatic cells in a lab dish and using a tool to silence the ERG gene; just like in the mice, these human cells also lost their identity markers and began producing inflammatory signals.
Perhaps the most revealing part of the study involved how these confused lymphatic cells interacted with the immune system. Using a sophisticated computer analysis, the team mapped the chemical conversations between the lymphatic vessels and the immune cells. In healthy lungs, these two groups communicate constantly, with the lymphatics sending signals that help guide immune cells and keep them in check. In the mice without ERG, these conversations broke down. The lymphatic cells stopped sending the necessary signals, and the immune cells, no longer receiving guidance, began to accumulate in the lung tissue. This suggests that ERG is not just a structural protein but a vital communication hub that keeps the immune system in balance. Without it, the lymphatic system fails to clear the area effectively, leading to a buildup of inflammation that could eventually pave the way for the scarring seen in severe lung disease.
The researchers were careful to note that while the loss of ERG caused significant inflammation and immune cell buildup, it did not, on its own, create the dense scar tissue characteristic of advanced fibrosis in these mice. This indicates that the loss of ERG is likely an early event that sets the stage for disease, creating an environment where inflammation thrives, but other factors are needed to drive the final stage of scarring. The findings align with what was seen in the human patients, where ERG levels were low and lymphatic identity genes were reduced. The study concludes that ERG is a critical guardian of lung health, responsible for maintaining the identity of lymphatic vessels and regulating their interaction with the immune system. When this guardian is lost, the lymphatic system falters, inflammation takes hold, and the lung becomes vulnerable to the damaging cycles of disease. This discovery points to a new way of looking at lung disorders, suggesting that protecting or restoring the function of these specific lymphatic switches could be a key to preventing or treating the inflammation that leads to lung failure.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.